Page 262 - The Netter Collection of Medical Illustrations - Integumentary System_ Volume 4 ( PDFDrive )

References Integumentary System

Feldman DS, Jordan C, Fonseca L. Orthopaedic manifestations of Isaacs H. Perinatal (fetal and neonatal) tuberous sclerosis: a review. Santos-Briz A, Cañueto J, Antúnez P, et al. Primary cutaneous
neurofibromatosis type 1. J Am Acad Orthop Surg. 2010;18: Am J Perinatol. 2009;26:755-760. localized amyloid elastosis. Am J Dermatopathol. 2010;32:
346-357. Jacobson L. Hypothalamic-pituitary-adrenocorticol axis regulation. 86-90.
Ferner RE. The neurofibromatoses. Pract Neurol. 2010;10: Endocrinol Metab Clin North Am. 2005;34:271-292. Shott SR. Down syndrome: common otolaryngologic manifesta-
82-93. James WD, Berger TG, Elston DM. Andrews’ Diseases of the Skin: tions. Am J Med Genet C Semin Med Genet. 2006;142:131-140.
Figueroa A, Correnti M, Avila M, et al. Keratocystic odontogenic Clinical Dermatology. Philadelphia: Saunders; 2006:650-652. Siraqusa M, Romano C, Cavallari V, et al. Localized elastosis per-
tumor associated with nevoid basal cell carcinoma syndrome: Jett K, Friedman JM. Clinical and genetic aspects of neurofibroma- forans serpiginosa in a boy with Down syndrome. Pediatr Der-
similar behavior to sporadic type? Otolaryngol Head Neck Surg. tosis 1. Genet Med. 2010;12:1-11. matol. 1997;14:244-246.
2010;142:179-183. Keane MG, Pyeritz RE. Medical management of Marfan syn- Spitz JL. Genodermatoses: A Clinical Guide to Genetic Skin Disorders.
Fujimoto N, Yajima M, Ohnishi Y, et al. Advanced glycation drome. Circulation. 2008;117:2802-2813. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
end product-modified? beta2-microglobulin is a component of Madan V, Williams J, Lear JT. Dermatological manifestations of Staser K, Yang FC, Clapp DW. Mast cells and the neurofibroma
amyloid fibrils of primary localized cutaneous nodular amyloido- Down’s syndrome. Clin Exp Dermatol. 2006;31:623-629. microenvironment. Blood. 2010;116:157-164.
sis. J Invest Dermatol. 2002;118:479-484. Mann JA, Siegel DH. Common genodermatoses: what the pediatri- Storr HL, Chan LF, Grossman AB, et al. Paediatric Cushing’s
García de Marcos JA, Dean-Ferrer A, Arroyo Rodríguez S, et al. cian needs to know. Pediatr Ann. 2009;38:91-98. syndrome: epidemiology, investigation and therapeutic advances.
Basal cell nevus syndrome: clinical and genetic diagnosis. Oral Muñoz-Pérez MA, Camacho F. Acanthosis nigricans: a new cutane- Trends Endocrinol Metab. 2007;18:167-174.
Maxillofac Surg. 2009;13:225-230. ous sign in severe atopic dermatitis and Down syndrome. J Eur Valin N, De Castro N, Garrait V, et al. Iatrogenic Cushing’s syn-
Gawthrop F, Mould R, Sperritt A, et al. Ehlers-Danlos syndrome. Acad Dermatol Venereol. 2001;15:325-327. drome in HIV-infected patients receiving ritonavir and inhaled
BMJ. 2007;335:448-450. Newell-Price J, Bertagna X, Grossman AB, et al. Cushing’s syn- fluticasone: description of 4 new cases and review of the litera-
Giordano R, Picu A, Broglio F, et al. Ghrelin, hypothalamus- drome. Lancet. 2006;367:1605-1617. ture. J Int Assoc Physicians AIDS Care. 2009;8:113-121.
pituitary-adrenal (HPA) axis and Cushing’s syndrome. Pituitary. Oldfeld EH. Cushing disease. J Neurosurg. 2003;98:948-951. Vandersteen A, Turnbull J, Jan W, et al. Cutaneous signs are
2005;7:243-248. Orlova KA, Crino PB. The tuberous sclerosis complex. Ann N Y important in the diagnosis of the rare neoplasia syndrome Carney
Goldberg LH, Firoz BF, Weiss GJ, et al. Basal cell nevus syndrome: Acad Sci. 2010;1184:87-105. complex. Eur J Pediatr. 2009;168:1401-1404.
a brave new world. Arch Dermatol. 2010;146:17-19. Pitak-Arnnop P, Chaine A, Oprean N, et al. Management of odon- Weyers W, Weyers I, Bonczkowitz M, et al. Lichen amyloidosus:
Gonzales EA. Marfan syndrome. J Am Acad Nurse Pract. 2009; togenic keratocysts of the jaws: a ten-year experience with 120 a consequence of scratching. J Am Acad Dermatol. 1997;37:
21:663-670. consecutive lesions. J Craniomaxillofac Surg. 2010;38:358-364. 923-928.
Greene WB. Netter’s Orthopaedics. Philadelphia: Saunders; 2006: Pivonello R, De Martino MC, De Leo M, et al. Cushing’s syn- Williams A, Davies S, Stuart AG, et al. Medical management
131-133. drome. Endocrinol Metab Clin Nprth Am. 2008;37:135-149. of Marfan syndrome: a time for change. Heart 2008;94:
Hamidi Asl K, Liepnieks JJ, Nakamura M, et al. A novel apolipo- Pursnani AK, Levy NK, Benito M, et al. Carney’s complex. J Am 414-421.
protein A-1 variant, Arg173Pro, associated with cardiac and cuta- Coll Cardiol. 2010;55:1395. Wiseman FK, Alford KA, Tybulewicz VL, et al. Down syndrome—
neous amyloidosis. Biochem Biophys Res Commun. 1999;257: Rabin KR, Whitlock JA. Malignancy in children with trisomy 21. recent progress and future prospects. Hum Mol Genet. 2009;
584-588. Oncologist. 2009;14:164-173. 18:R75-R83.
Horvath A, Bertherat J, Groussin L, et al. Mutations and polymor- Raff H, Findling JW. A physiological approach to diagnosis of the Zhang L, Smyrk TC, Young WF, et al. Gastric stromal tumors in
phisms in the gene encoding regulatory subunit type 1-alpha of Cushing syndrome. Ann Intern Med. 2003;138:980-991. Carney triad are different clinically, pathologically, and behavior-
protein kinase A (PRKAR1A): an update. Hum Mutat. 2010;31: Ruggieri M. The different forms of neurofibromatosis. Childs Nerv ally from sporadic gastric gastrointestinal stromal tumors: find-
369-379. Syst. 1999;15:295-308. ings in 104 cases. Am J Surg Pathol. 2010;34:53-64.

248 THE NETTER COLLECTION OF MEDICAL ILLUSTRATIONS